Swisscanto Holding

Founded in 2016, ANYbotics develops autonomous legged robots designed for industrial applications. These robots are equipped with features such as docking stations, robust sensing capabilities, and waterproofing. They also offer tools for reading instruments, monitoring equipment health, detecting events, and inspecting complex environments. The company aims to improve worker safety, increase productivity, and support sustainable operations in industries like oil and gas, power, mining, chemicals, construction, and transportation.

Founded in 2016, ANYbotics develops autonomous legged robots designed for industrial applications. These robots are equipped with features such as docking stations, robust sensing capabilities, and waterproofing. They also offer tools for reading instruments, monitoring equipment health, detecting events, and inspecting complex environments. The company aims to improve worker safety, increase productivity, and support sustainable operations in industries like oil and gas, power, mining, chemicals, construction, and transportation.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.